Pituitary & hypothalamus

The clinical and metabolic characteristics of children and adolescents with hypothalamic dysfunction: A single‐centre study from China

Clin Endocrinol (Oxf)Published Retrospective study

Authors' conclusion

Intracranial tumour was the most common aetiology in children and adolescents with hypothalamic dysfunction. In addition, these patients presented a worse metabolic profile on average than healthy patients.

Study context

Population
Chinese children and adolescents with hypothalamic dysfunction, single medical centre in Beijing, China, 1989–2019
Participants
40 children
Exposure
Hypothalamic dysfunction vs sex- and age-matched controls and sex-, age- and body mass index (BMI)-matched controls
  • Hypothalamic dysfunctionn = 40
Outcome
Aetiology and symptoms of hypothalamic dysfunction
Methodological detailssingle-centre
  • Single-centre

Main finding

As reported in the abstract

Intracranial tumour (most common aetiology, especially germ cell tumours)

37.5%

Hypopituitarism

82.5%

Weight gain

72.5%

Central diabetes insipidus

70.0%

Observational data: associations, not effects.

Further findings

Serum ALT, AST, γ-glutamyl transpeptidase, uric acid, total cholesterol, TG and LDL-C

Significantly higher in hypothalamic dysfunction than sex- and age-matched controls and sex-, age- and BMI-matched controls
all p < 0.05

Albumin and HDL-C

Lower in hypothalamic dysfunction than controls
P < 0.05

Metabolic diseases

Patients with metabolic diseases
95% (38/40)

Incidence of dyslipidaemia and hyperuricemia

Significantly higher in hypothalamic dysfunction than sex- and age-matched controls and sex-, age- and BMI-matched controls
both p < 0.05

Original publication

The clinical and metabolic characteristics of children and adolescents with hypothalamic dysfunction: A single‐centre study from China. Clin Endocrinol (Oxf). Published 5 September 2022. doi:10.1111/cen.14814

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.